Fsd Pharma Inc Cl B (HUGE) |
|
2.91 0.04 (1.39%)
|
08-13 16:00 |
|
Open: |
2.82 |
Pre. Close: |
2.87 |
|
High:
|
2.95 |
Low:
|
2.79 |
|
Volume:
|
137,201 |
Market Cap:
|
38M |
|
|
|
|
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. FSD Pharma Inc. has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products; and collaborative research and development agreement with Solarvest BioEnergy Inc. The company is headquartered in Cobourg, Canada. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.951 - 2.969 |
2.969 - 2.986 |
|
Low:
|
2.749 - 2.77 |
2.77 - 2.789 |
|
Close:
|
2.878 - 2.909 |
2.909 - 2.938 |
|
Technical analysis |
as of: 2020-08-13 4:35:05 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 6.20  One year: 8.02 |
| Support: |
Support1: 2.79 Support2: 2.32 |
| Resistance: |
Resistance1: 5.31 Resistance2: 6.87 |
| Pivot: |
3.37 |
| Moving Average: |
MA(5): 2.97 MA(20): 3.50
MA(100): 3.59 MA(250): 6.13 |
| MACD: |
MACD(12,26): -0.26 Signal(9): -0.19 |
| Stochastic oscillator: |
%K(14,3): 1.98 %D(3): 2.31 |
| RSI: |
RSI(14): 34.26 |
| 52-week: |
High: 18.09 Low: 2.39 Change(%): -83.9 |
| Average Vol(K): |
3-Month: 83238 10-Days: 42541 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.HUGE has closed above bottom band by 22.0%. Bollinger Bands are 7.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 13 Aug 2020
Form N-PX Exchange Listed Funds For: Jun 30 - StreetInsider.com
Fri, 31 Jul 2020
Yahoo U: Breaking Down Stock Splits - Yahoo Money
Mon, 13 Jul 2020
Big Lots - Consensus Indicates Potential 12.0% Upside - DirectorsTalk Interviews
Mon, 22 Jun 2020
A Look Into FSD Pharma's Price Over Earnings - Benzinga
Wed, 03 Jun 2020
Coronavirus Treatment: FSD Pharma Rockets On Test Plans In Covid-19 - Investor's Business Daily
Wed, 29 Apr 2020
Investing During Coronavirus: Stocks Sink Lower as Stimulus Talks Drag On - InvestorPlace
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqCM |
| Sector: Healthcare |
| Industry: Drug Manufacturers Specialty & Generic |
| Shares Out. (M) |
|
| Shares Float (M) |
|
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
-0.039 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
|
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
